Brisa's Q1 Turnaround Was Dramatic. Today's H1 Print Tells If It Lasts.

The headline from the competitor desk is a routine filing notice - Brisa Bridgestone Sabancı releases its consolidated H1 2026 operating review. But the subtext is worth separating from the calendar event. The question is not whether the company is reporting again. The question is whether the dramatic Q1 inflection was the beginning of a durable turnaround or a sharp base effect that fades when you widen the frame.

Brisa's H1 2026 interim results - covering the six months through June 30 - are scheduled for release after trading hours today, August 5. The company confirmed the date in a disclosure notice last week. For investors watching Turkey's largest tire manufacturer, today is the first data point that tells you whether the first-quarter story holds.

The Q1 inflection

To understand what the H1 print needs to confirm, you have to start with what Q1 delivered. Brisa reported sales of TRY 11.98 billion in the first quarter of 2026, up from TRY 10.68 billion in Q1 2025 - a 12.2% increase. More important than revenue is the bottom-line flip: net income came in at TRY 28 million, a stark reversal from a TRY 662 million net loss a year earlier. EBITDA grew 55% year-over-year to TRY 1.7 billion, pushing the margin to 14.5%.

A 55% EBITDA jump from a single quarter is not incremental improvement; it is a regime change in earnings power. That kind of inflection usually comes from one or more of three things: pricing recovery, volume acceleration, or cost restructuring. Brisa's management did not publicly break down the Q1 mix with the granularity investors would need to attribute the swing, so the H1 numbers are the first test of whether the Q1 surge was broad-based or front-loaded.

The full-year 2025 anchor

The comparison frame matters. For the full year 2025, Brisa reported revenue of TRY 41.3 billion, down 8.6% year-over-year. EBITDA was TRY 5.4 billion with a margin of 13.2%. That was a contraction year - revenue fell and margins compressed - which makes the Q1 2026 rebound look even sharper by arithmetic alone.

A low base makes recovery look faster. That is the mechanical reality. Q1 2025 was a quarter where the company lost TRY 662 million at the bottom line, dragged down by the same forces that weighed on the full year. So the Q1 turnaround partly reflects returning from a hole rather than growing from a peak. The H1 print separates the two. If Q2 2026 prints near or above Q1's TRY 1.7 billion EBITDA, the recovery has depth. If Q2 materially softens, you're looking at a quarter of base-effect arithmetic, not a structural shift.

What the factor stack says

Stepping back from the quarter-by-quarter scoreboard, Brisa's trailing metrics paint a company caught between recovery and headwinds. Trailing revenue sits at TRY 42.65 billion. The operating margin is 11.65%, which is decent for a tire manufacturer but not exceptional. Return on assets is 5.33%, suggesting reasonable asset utilization. But return on equity is negative at -1.70%, which tells you that leverage or balance sheet dynamics are still working against shareholders despite the operating improvement.

A negative ROE on a company generating positive operating income is a balance sheet signal. It means net debt, equity drawdown, or non-operating charges are outweighing the earnings contribution from the tire business itself. That is the detail the Q1-to-H1 transition should help resolve. If H1 net income is materially higher than Q1's TRY 28 million, the equity story improves. If it is close to flat or lower, the ROE problem persists and the turnaround stays half-finished.

The market currently values Brisa at approximately TRY 25.2 billion in market capitalization. That puts the stock at roughly 0.6 times trailing revenue and 4.7 times the last reported full-year EBITDA - numbers that would be cheap for a growth operator and rich for a company still wrestling with negative ROE. The valuation sits in the middle, which is where the H1 print moves the debate.

What to watch in today's release

Three numbers from the H1 2026 operating review will carry the most weight:

• H1 EBITDA and margin trend. If the first half shows EBITDA margin above or near Q1's 14.5%, the pricing or cost story is durable. A pullback to the FY 2025 full-year average of 13.2% would suggest Q1 was the peak of the inflection.
• H1 net income trajectory. Q1 was TRY 28 million on a TRY 662 million loss base. The H1 total tells you whether Q2 added profit or merely held the line.
• Cash flow and leverage. The Q1 release referenced cash flow generation as a positive, but the FY 2025 narrative centered on "improved cash flow and leverage" while revenue fell. You need H1 operating cash flow to know whether the cash generation improving alongside earnings is a pattern or a one-quarter event.

Portfolio framing

Brisa doesn't belong in a growth sleeve at this point. It belongs in a recovery position - the kind of name that either validates a margin turnaround thesis or reveals that the base effect was doing more work than the business. The stock is not a barbell hedge, not a dividend income play, and not a momentum name. It is an operating leverage bet on a single industry player in a high-inflation, high-volatility economy.

If H1 confirms that Q1 was the floor and not the ceiling, Brisa becomes a candidate for the turnaround sleeve. If H1 softens materially, the factor stack still shows a company with a negative ROE trading at a valuation that assumes improvement that hasn't proven durable yet. In that case, the rating stays at hold until a second consecutive quarter of EBITDA above 14% gives you a signal that the recovery has teeth.

Today's release is the first real test. The Q1 numbers were a headline. The H1 numbers are the story.